Cat.#: ASSD-138
| Description | A3AR covalent antagonist.Binds irreversibly. Apparent pKi values at A3ARs are 6.9 and 8.0 (after 4h), where a Ki shift indicates a covalent mode of action. |
| Size | 50 μg |
| Chemical Name | 4-[3-(8-Methoxy-2,4-dioxo-3-propylpurino[7,8-a]pyridin-1-yl)propylcarbamoyl]benzenesulfonyl fluoride |
| Molecule Weight | 517.5 |
| Molecular formula | C23H24FN5O6S |
| PubChem identifier | 155513958 |
| Purity | >95% |
| Solubility | Soluble in DMSO |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-141 | MTT (AC141) | 500 mg, 1 g | inquiry |
| ASSD-194 | 7-(Diethylamino)coumarin-3-carboxylic acid (AC194) | 100 mg | inquiry |
| ASSD-112 | Propidium Iodide Staining Solution (1mg/ml) in water (AC112) | 1 mL | inquiry |
| ASSD-105 | Hoechst 33342 (AC105) | 10 mg, 100 mg | inquiry |
| ASSD-129 | Fluorescent 5-HT1A antagonist [NAN-190] (AC129) | 50 μg | inquiry |
| ASSD-145 | Oxazole Yellow Iodide 1mM solution (in 1mL DMSO) (AC145) | 1 mL | inquiry |
| ASSD-134 | FITC Phalloidin (AC134) | 300 tests, 100μg | inquiry |
| ASSD-188 | Dansyl Chloride (AC188) | 1 g | inquiry |
| ASSD-150 | Luminol (AC150) | 1 g | inquiry |
| ASSD-177 | Fluorescein 5-Maleimide (AC177) | 25 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.